• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Chondrosarcoma-associated gene 2/3 protein (CSAG2)

ACP09434

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP09434 Target NameCSAG2
Target SynonymsCSAG2; TRAG3;; CSAG3; CSAG3AChondrosarcoma-associated gene 2/3 protein; Cancer/testis antigen 24.2; CT24.2; Taxol-resistant-associated gene 3 protein; TRAG-3FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-127
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9Y5P2
Background Information
  • Uniprot Id

    Q9Y5P2

  • Target Species

    Human

  • Target Name

    CSAG2

  • Target Full Name

    Chondrosarcoma-associated gene 2/3 protein

  • Target Function

    Drug-resistance related protein, its expression is associated with the chemotherapy resistant and neoplastic phenotype. May also be linked to the malignant phenotype.

  • Target Tissue Specificity

    Weakly expressed in kidney. Expressed in various tumor cell lines including carcinomas, myeloid and lymphoid malignancies, melanomas and prostate cancer. Overexpressed in taxol-resistant breast cancer line MDA 435TR and the doxorubicin-resistant multiple

  • Target Synonyms

    CSAG2; TRAG3;; CSAG3; CSAG3AChondrosarcoma-associated gene 2/3 protein; Cancer/testis antigen 24.2; CT24.2; Taxol-resistant-associated gene 3 protein; TRAG-3

Inquire Recombinant Human Chondrosarcoma-associated gene 2/3 protein (CSAG2) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification